Treatment of basal cell carcinoma located in the head and neck region with intralesional interferon alpha-2a - Evaluation of long-term follow-up results

BOSTANCI S., Kocyigit P., Alp A., Erdem C., Gurgey E.

CLINICAL DRUG INVESTIGATION, vol.25, no.10, pp.661-667, 2005 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 25 Issue: 10
  • Publication Date: 2005
  • Doi Number: 10.2165/00044011-200525100-00005
  • Journal Name: CLINICAL DRUG INVESTIGATION
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.661-667
  • Ankara University Affiliated: Yes

Abstract

Objective: Intralesional injections of interferon have been reported to provide successful results in the treatment of basal cell carcinoma. However, there are only a few reports describing the long-term efficacy of this therapy. The aim of our study was to evaluate the efficacy and long-term results of interferon alpha-2a (IFN alpha-2a) in the treatment of basal cell carcinoma.